NW
IP & Commercial StrategyRegulatory & Commercial Strategy

Technology transfer of nanobiosensor and point-of-care technologies

By Institut Catala de Nanociencia i Nanotecnologia (ICN2)

Technology transfer of our nanobiosensor and point-of-care technologies. Enhanced usability facilitates a smoother transition between our laboratory prototypes to products, leading to increased commercialisation potential. We work in providing platforms, tools, IP, open-source and custom applications targeted to filling gaps in diagnostics.